Description
Author: Dr. Brett J Skinner, Ph.D.
This study examines the publicly available empirical evidence about the drug costs of private insurers in Canada, in the context of other privately insured health costs, in order to test the validity of assertions that the cost of new drugs cannot be sustainably insured by the private sector without further government regulation.
